Pharmaron Beijing Co., Ltd.
Status: Publicly traded
Direct answer
Pharmaron Beijing Co., Ltd. is publicly traded on HKSE under the ticker 3759.HK.
Pharmaron Beijing Co., Ltd. is a global contract research, development, and manufacturing organization (CRDMO) that supports the life sciences sector. Operating across North America, Europe, Mainland China, and other Asian regions, the company delivers comprehensive pharmaceutical research and development services worldwide. Its diverse operations are structured into five key divisions: Laboratory Services;...
Can you invest in Pharmaron Beijing Co., Ltd.?
Yes. Pharmaron Beijing Co., Ltd. is publicly traded on HKSE under the ticker 3759.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Pharmaron Beijing Co., Ltd.
Detailed equity research is provided by MarketSnap.